PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression.

MLA

Yadav, Neera, et al. “PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression.” Pharmaceutics, vol. 14, no. 7, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/pharmaceutics14071326.

APA

Yadav, N., Tripathi, A. K., & Parveen, A. (2022). PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics, 14(7), N.PAG. https://doi.org/10.3390/pharmaceutics14071326

Chicago

Yadav, Neera, Amit Kumar Tripathi, and Amna Parveen. 2022. “PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression.” Pharmaceutics 14 (7): N.PAG. doi:10.3390/pharmaceutics14071326.